Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

15 Jul 2013 17:15

RNS Number : 3688J
Plant Health Care PLC
15 July 2013
 



15 July 2013

 

PLANT HEALTH CARE PLC("Plant Health Care" or the "Company")

 

Director's dealing

 

Plant Health Care (AIM / CISX: PHC.L) announces that it has entered into a binding agreement with Mr John Brady, a director of the Company. Under the agreement, Mr Brady shall exercise, in two equal tranches on 15 October 2013 and 13 November 2013 all of his options over unissued shares in the Company, which equate to 975,000 Plant Health Care shares ("Shares"). On each date Mr Brady shall sell such number of Shares as is sufficient to cover the exercise price and his associated tax liability arising from the exercise. Any sale of Shares shall be at the prevailing market price and subject to sufficient demand in the market. Further details, using the assumptions specified so as to provide working examples, are set out below:

 

15 October 2013

Mr Brady shall exercise 487,500 options at an exercise price of 37p per Share and sell such number of Shares as shall cover the amount of the aggregate exercise price and his associated tax liability. Assuming a prevailing Share price of 78.5p, being the closing Share price on 12 July 2013, the funds required to cover the exercise price and taxes would equate to approximately £261,000 which would require the disposal of approximately 332,485 Shares*.

 

13 November 2013

56,025 options with an exercise price of 71p per Share (provided they are below the then current market price) and sell such number of Shares as shall cover the amount of the aggregate exercise price and his associated tax liability. Assuming a prevailing share price of 78.5p, being the closing share price on 12 July 2013, the funds required to cover the exercise price and taxes would equate to approximately £274,000 which would require the disposal of approximately 349,045 Shares*.

 

 

 

Notes:

1. The closing share price of 78.5p refers to the closing middle market price of a Plant Health Care share on 12 July 2013 as derived from the daily official list of the London Stock Exchange plc.

2. *An exchange rate of £/$1.5118 has been assumed which was derived from data provided on FT.com by WM/Reuters as at 4.00 p.m. London time on 12 July 2013 (being the last practicable dealing date prior to the date of this announcement).

 

For further information please contact:

 

Plant Health Care plc

Dr. Chris Richards

Chairman

Tel: +44 (0)20 7250 1446

Nomura Code Securities

Clare Terlouw / Chris Golden

Tel: +44 (0)20 7776 1200

www.nomuracode.com

Powerscourt

Paul Durman / Sophie Moate

Tel: +44 (0)20 7250 1446

paul.durman@powerscourtgroup.

com

sophie.moate@powerscourtgroup

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFUFIIFDSEIW
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.